Cargando…
A p-Tyr42 RhoA Inhibitor Promotes the Regeneration of Human Corneal Endothelial Cells by Ameliorating Cellular Senescence
The development of treatment strategies for human corneal endothelial cells (hCECs) disease is necessary because hCECs do not regenerate in vivo due to the properties that are similar to senescence. This study is performed to investigate the role of a p-Tyr42 RhoA inhibitor (MH4, ELMED Inc., Chunche...
Autores principales: | Kim, Hyeon Jung, Hwang, Jin Sun, Noh, Kyung Bo, Oh, Sun-Hee, Park, Jae-Bong, Shin, Young Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295357/ https://www.ncbi.nlm.nih.gov/pubmed/37371916 http://dx.doi.org/10.3390/antiox12061186 |
Ejemplares similares
-
Distinct dual roles of p-Tyr42 RhoA GTPase in tau phosphorylation and ATP citrate lyase activation upon different Aβ concentrations
por: Cap, Kim Cuong, et al.
Publicado: (2020) -
Regulation of RhoA activity by the cellular prion protein
por: Kim, Hee-Jun, et al.
Publicado: (2017) -
miR-30c-1 encourages human corneal endothelial cells to regenerate through ameliorating senescence
por: Bae, Younghwan, et al.
Publicado: (2021) -
Adipose Mesenchymal Stem Cell-Derived Exosomes Promote the Regeneration of Corneal Endothelium Through Ameliorating Senescence
por: Ryu, Yunkyoung, et al.
Publicado: (2023) -
Localized suppression of RhoA activity by Tyr31/118-phosphorylated paxillin in cell adhesion and migration
por: Tsubouchi, Asako, et al.
Publicado: (2002)